Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Dipti Patel-Donnelly
An Open-Label, Phase 2 Trial of Entospletinib (GS-9973), a Selective Spleen Tyrosine Kinase Inhibitor, in Diffuse Large B-Cell Lymphoma
Clinical Lymphoma, Myeloma and Leukemia
Cancer Research
Oncology
Hematology
Related publications
Diffuse Large B-Cell Lymphoma Presenting in the Leukemic Phase
Autopsy and Case Reports
Diffuse Large B-Cell Lymphoma
Mocetinostat for Relapsed Classical Hodgkin's Lymphoma: An Open-Label, Single-Arm, Phase 2 Trial
The Lancet Oncology
Oncology
Phase II Open Label Study of the Oral Vascular Endothelial Growth Factor-Receptor Inhibitor PTK787/ZK222584 (Vatalanib) in Adult Patients With Refractory or Relapsed Diffuse Large B-Cell Lymphoma
Leukemia and Lymphoma
Cancer Research
Oncology
Hematology
B-Cell Receptor Signaling in Diffuse Large B-Cell Lymphoma
Seminars in Hematology
Hematology
Diffuse Large B-Cell Lymphoma: A Case Report
Clinical and Experimental Health Sciences
Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
PLoS ONE
Multidisciplinary
ALK -Positive Diffuse Large B-Cell Lymphoma
Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer Research
Oncology
Genetics
Hematology
Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
